Proteomic analysis of Src family kinase phosphorylation states in cancer cells suggests deregulation of the unique domain
(se abrirá en una nueva ventana)
Autores:
Ruiz-Saenz A, Zahedi F, Peterson E, Yoo A, Dreyer CA, Spassov DS, Oses-Prieto J, Burlingame A, Moasser MM
Publicado en:
Mol Cancer Res, Edición 19(6), 2021, Página(s) 957-967, ISSN 1541-7786
Editor:
American Association for Cancer Research
DOI:
10.1158/1541-7786.mcr-20-0825
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors
(se abrirá en una nueva ventana)
Autores:
Ruiz-Saenz A, Atreya CE, Wang C, Pan B, Dreyer CA, Brunen D, Prahallad A, Muñoz DP, Ramms DJ, Burghi V, Spassov DS, Fewings E, Hwang YC, Cowdrey C, Moelders C, Schwarzer C, Wolf DM, Hann B, VandenBerg SR, Shokat K, Moasser MM, Bernards R, Gutkind JS, van 't Veer LJ, Coppé JP. A
Publicado en:
Nature Cancer, Edición 4(2), 2023, Página(s) 240–256, ISSN 2662-1347
Editor:
Nature publishing group
DOI:
10.1038/s43018-022-00508-5
A role of salt bridges in mediating drug potency: A lesson from the N-myristoyltransferase inhibitors
(se abrirá en una nueva ventana)
Autores:
Spassov DS, Atanasova M, Doytchinova I
Publicado en:
Front Mol Biosci, Edición 9, 2023, Página(s) 1066029, ISSN 2296-889X
Editor:
Frontiers
DOI:
10.3389/fmolb.2022.1066029
Novel Hits for N-Myristoyltransferase Inhibition Discovered by Docking-Based Screening
(se abrirá en una nueva ventana)
Autores:
Spassov DS, Atanasova M, Doytchinova I.
Publicado en:
Molecules, Edición 27(17), 2022, Página(s) 5478, ISSN 1420-3049
Editor:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/molecules27175478
